CD247 and neoplasm: Patient-derived T cells are modified to express a CAR that is mainly composed of extracellular single-chain variable fragment (scFv) recognizing tumor antigens, transmembrane domain, intracellular immunoreceptor tyrosine-based activation motifs (ITAMs) from CD3 zeta chain (CD3ζ) and co-stimulatory domain [9].